Literature DB >> 7577396

Neonatal Fanconi syndrome due to deficiency of complex III of the respiratory chain.

A A Morris1, R W Taylor, M A Birch-Machin, M J Jackson, M G Coulthard, L A Bindoff, R J Welch, N Howell, D M Turnbull.   

Abstract

Fanconi syndrome is an important presentation of respiratory chain disease. We report three patients who presented in the neonatal period with Fanconi syndrome, lactic acidosis and intrauterine growth retardation. In all three patients the major biochemical defect was in complex III of the mitochondrial respiratory chain, a relatively uncommon defect. The diagnosis could only be made by muscle biopsy as the defect was not expressed in cultured skin fibroblasts. Treatment with vitamins C and K3 and ubiquinone did not alter the course of the disease and all patients died before the age of 4 months.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7577396     DOI: 10.1007/BF00866711

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  20 in total

1.  Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy.

Authors:  A Rötig; V Cormier; S Blanche; J P Bonnefont; F Ledeist; N Romero; J Schmitz; P Rustin; A Fischer; J M Saudubray
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

2.  Subunit arrangement in beef heart complex III.

Authors:  D González-Halphen; M A Lindorfer; R A Capaldi
Journal:  Biochemistry       Date:  1988-09-06       Impact factor: 3.162

3.  Biochemical and molecular studies of mitochondrial function in diabetes insipidus, diabetes mellitus, optic atrophy, and deafness.

Authors:  M J Jackson; L A Bindoff; K Weber; J N Wilson; P Ince; K G Alberti; D M Turnbull
Journal:  Diabetes Care       Date:  1994-07       Impact factor: 19.112

4.  31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle.

Authors:  S Eleff; N G Kennaway; N R Buist; V M Darley-Usmar; R A Capaldi; W J Bank; B Chance
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

5.  Mitochondrial myopathy with lactic acidaemia, Fanconi-De Toni-Debré syndrome and a disturbed succinate: cytochrome c oxidoreductase activity.

Authors:  W Sperl; W Ruitenbeek; J M Trijbels; R C Sengers; A M Stadhouders; J P Guggenbichler
Journal:  Eur J Pediatr       Date:  1988-05       Impact factor: 3.183

6.  Nuclear complementation restores mtDNA levels in cultured cells from a patient with mtDNA depletion.

Authors:  A G Bodnar; J M Cooper; I J Holt; J V Leonard; A H Schapira
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

7.  Succinate-cytochrome c reductase: assessment of its value in the investigation of defects of the respiratory chain.

Authors:  R W Taylor; M A Birch-Machin; K Bartlett; D M Turnbull
Journal:  Biochim Biophys Acta       Date:  1993-06-19

8.  Skeletal muscle mitochondrial beta-oxidation. A study of the products of oxidation of [U-14C]hexadecanoate by h.p.l.c. using continuous on-line radiochemical detection.

Authors:  N J Watmough; A K Bhuiyan; K Bartlett; H S Sherratt; D M Turnbull
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

9.  Maternally inherited duplication of the mitochondrial genome in a syndrome of proximal tubulopathy, diabetes mellitus, and cerebellar ataxia.

Authors:  A Rötig; J L Bessis; N Romero; V Cormier; J M Saudubray; P Narcy; G Lenoir; P Rustin; A Munnich
Journal:  Am J Hum Genet       Date:  1992-02       Impact factor: 11.025

10.  de Toni-Fanconi-Debré syndrome with Leigh syndrome revealing severe muscle cytochrome c oxidase deficiency.

Authors:  H Ogier; A Lombes; H R Scholte; B T Poll-The; M Fardeau; J Alcardi; B Vignes; P Niaudet; J M Saudubray
Journal:  J Pediatr       Date:  1988-05       Impact factor: 4.406

View more
  14 in total

Review 1.  Clinical mitochondrial genetics.

Authors:  P F Chinnery; N Howell; R M Andrews; D M Turnbull
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

2.  A mitochondrial DNA deletion presenting with corneal clouding and severe Fanconi syndrome.

Authors:  Joyce J Lee; Laura M Tripi; Richard W Erbe; Sudha Garimella-Krovi; James E Springate
Journal:  Pediatr Nephrol       Date:  2012-01-20       Impact factor: 3.714

Review 3.  Mitochondrial disorders and the kidney.

Authors:  P Niaudet
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

Review 4.  Mitochondrial disorders caused by mutations in respiratory chain assembly factors.

Authors:  Francisca Diaz; Heike Kotarsky; Vineta Fellman; Carlos T Moraes
Journal:  Semin Fetal Neonatal Med       Date:  2011-06-15       Impact factor: 3.926

Review 5.  Mitochondria in Acute Kidney Injury.

Authors:  Kenneth M Ralto; Samir M Parikh
Journal:  Semin Nephrol       Date:  2016-01       Impact factor: 5.299

Review 6.  Toxicity of antiretroviral nucleoside and nucleotide analogues: is mitochondrial toxicity the only mechanism?

Authors:  G Moyle
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

7.  Renal pathology in children with mitochondrial diseases.

Authors:  Elena Martín-Hernández; M Teresa García-Silva; Julia Vara; Yolanda Campos; Ana Cabello; Rafael Muley; Pilar Del Hoyo; Miguel Angel Martín; Joaquín Arenas
Journal:  Pediatr Nephrol       Date:  2005-06-24       Impact factor: 3.714

8.  Screening of BCS1L mutations in severe neonatal disorders suspicious for mitochondrial cause.

Authors:  Vineta Fellman; Susanna Lemmelä; Antti Sajantila; Helena Pihko; Irma Järvelä
Journal:  J Hum Genet       Date:  2008-04-02       Impact factor: 3.172

Review 9.  Mitochondrial dysfunction in inherited renal disease and acute kidney injury.

Authors:  Francesco Emma; Giovanni Montini; Samir M Parikh; Leonardo Salviati
Journal:  Nat Rev Nephrol       Date:  2016-01-25       Impact factor: 28.314

Review 10.  Renal involvement in mitochondrial cytopathies.

Authors:  P Niaudet; A Rötig
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.